LabCorp, a leading global life sciences company that is deeply integrated in guiding patient care, and Envigo, a leading provider of nonclinical contract research services and research models, ...
The positions in the table below reflect the Labcorp Drug Development's position overall, domestically, within their sector, and in various subject areas based on their Share. Each position links to ...
Barchart on MSN
Labcorp Holdings’ Q3 2025 Earnings: What to Expect
With a market cap of $22.9 billion, Labcorp Holdings Inc. (LH) is a leading global life sciences company that provides ...
"Labcorp is committed to advancing its diagnostic capabilities through the adoption of innovative technologies," said Marcia ...
Burlington-based Labcorp has launched the first blood-based test cleared by the U.S. Food and Drug Administration (FDA) for aiding in the diagnosis of Alzheimer's disease.
Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the third quarter of 2025 before the market opens on ...
Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of ...
TipRanks on MSN
Labcorp Holdings to Release Q3 2025 Financial Results
Detailed price information for Laboratory Corp of America Holdings (LH-N) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback